Livforsakringsbolaget Skandia, Omsesidigt West Pharmaceutical Services Inc Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$318.29 - $392.21 $28,646 - $35,298	90 Added 90.0%	190 $66,000
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $98,432 - $137,460	-400 Reduced 80.0%	100 $25,000
Q2 2022 Aug 16, 2022	SELL	$280.61 - $420.45 $56,122 - $84,090	-200 Reduced 28.57%	500 $151,000
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $281,575 - $329,938	-700 Reduced 50.0%	700 $328,000
Q2 2021 Jul 13, 2021	BUY	$284.77 - $363.2 $170,862 - $217,920	600 Added 75.0%	1,400 $503,000
Q1 2020 Apr 22, 2020	BUY	$128.96 - $174.76 $25,792 - $34,952	200 Added 33.33%	800 $122,000
Q4 2019 Jan 28, 2020	BUY	$137.6 - $151.21 $82,560 - $90,726	600 New	600 $90,000

802

64.3M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.